Efficacy and Safety of S-ketamine in Elderly Patients Undergoing Non-cardiac Surgery: a RCT(ESSENCE)

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

December 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Postoperative Pain
Interventions
DRUG

Esketamine hydrochloride

Intravenous infusion of esketamine: after induction, a single dose of 0.25 mg/kg before skin incision,and continuous 0.125 mg/kg/h until 30 min before surgery was stopped.

DRUG

Saline

after induction, a single intravenous infusion of an equal amount of 0.9% saline before skin incision, followed by a continuous infusion at the same rate as the test group until 30 min before surgical cessation.

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER